3) Yet the so-called “Infection Prevention Society” thinks hygiene and hand sanitizers and “enhanced cleaning is what’s more important to mention somehow. These dinosaurs need to GTFO.
📝REPORT—“Countries with poor results had uncoordinated approaches that devalued science, denied potential impact of pandemic, delayed comprehensive action, & allowed distrust to undermine efforts”
2) “On the basis of the panel's comparative analysis of 28 countries from across the spectrum of responses that is published alongside the report, it is clear countries with successful responses had timely triage and referral of suspected COVID-19 cases to ensure swift case…
3) “identification and contact tracing, and provided designated isolation facilities, either for all or for those unable to self-isolate. High-performing countries also developed partnerships on multiple levels across government sectors and with groups outside government…
⚠️“dramatic rise in UK cases of a variant first discovered in India could undermine roadmap for reopening”, scientists caution. One of 3 key 🇮🇳variants, #B161712, now surged to 6% of all variants in UK, WHO & England both upgraded to “variant of concern”.🧵theguardian.com/world/2021/may…
2) Prof @chrischirp, of University College London and member of @IndependentSage experts, speaking in a personal capacity said rise in B.1.617.2 cases was concerning enough to delay the next stage of the roadmap scheduled for Monday, when a range of restrictions are to be lifted.
3) “the second most common variant in the UK. Wellcome Sanger Institute’s Covid-19 genomic surveillance data – **which excludes recent travellers and surge testing specimens** – suggests about 6.1% of Covid genomes in England sequenced in the 4 weeks to 24 April are B.1.617.2.
Worrisome cluster at Singapore 🇸🇬 @ChangiAirport of many #B1617 Indian variant (+pending). 92% of aviation staff vaccinated—of primary cases: 11 breakthroughs in vaccinated airport staff, 3 in unvaccinated staff, 4 non-airport staff unvaccinated. #MaskUp🧵 channelnewsasia.com/news/singapore…
2) The Civil Aviation Authority of Singapore (CAAS) and Changi Airport Group (CAG) said on Sunday that all workers in Changi Airport’s operating terminals will be tested for COVID-19 in a special testing operation.
3) About 9,000 workers from Terminal 1, Terminal 3 and Jewel Changi Airport will undergo these tests. Terminal 2 is not open.
All vaccinated frontline airport workers will also be tested every 14 days as part of rostered routine testing, up from the 28 days previously.
⚠️WARNING TO SCHOOL DISTRICTS: A top seller of “bipolar ionization” (avoid!) air purification cleaners among schools is facing a federal class action lawsuit that its devices could produce toxic chemicals in classroom air & do not work to fight #COVID19.🧵 motherjones.com/coronavirus-up…
2) Bipolar ionization (avoid this type) maker “Global Plasma Solutions preys on people desperate to cleanse the air and protect themselves from ailments including the COVID-19 virus,” alleges the complaint filed in US District Court in Delaware on May 7.
3) “Defendant’s ‘profits over people’ scheme won the company acclaim, publicity, and generated hundreds of millions of dollars in sales.”
QUAD TEST—small device resembling an inkjet-printer cartridge, so-called quad test, now available at thousands of clinics around the country, could detect #SARSCoV2, two types of influenza and the respiratory syncytial virus—in just 30 minutes. Huge. nytimes.com/2021/05/11/hea…
2) “I remember giving myself a fist bump like, ‘Yes! It’s not Covid. It’s the flu,’” said Dr. Gustafson, chief of emergency medicine of the Sanford USD Medical Center in Sioux Falls, S.D.
3) “He relayed the news to the patient and his wife, happily adding that there was a treatment he could offer right away, Tamiflu. “The relief in their eyes above their masks was very satisfying,” Dr. Gustafson said.
2) Yet, that is just what @jairbolsonaro did again just a few days ago… he doubled down on ivermectin (despite Merck the maker of the drug denying any benefits for Covid!!!) google.com/amp/s/www.cnnb…
3) Merck: “No scientific basis for a potential therapeutic effect against COVID-19 from pre-clinical studies;
No meaningful evidence for clinical activity or clinical efficacy in patients with COVID-19 disease, and;